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Abstract
Background: There is a demand for strategies to promote smoking cessation in high-risk
populations like smoking pregnant women and their partners. The objectives of this study were to
investigate parental smoking behaviour during pregnancy after introduction of a prenatal,
structured, multi-disciplinary smoking cessation programme in primary care, and to compare
smoking behaviour among pregnant women in the city of Trondheim with Bergen and Norway.
Methods: Sequential birth cohorts were established to evaluate the intervention programme from
September 2000 to December 2004 in primary care as a part of the Prevention of Allergy among
Children in Trondheim study (PACT). The primary outcome variables were self reported smoking
behaviour at inclusion and six weeks postnatal. Data from the Medical Birth Registry of Norway
(MBR) were used to describe smoking cessation during pregnancy in Trondheim, Bergen and
Norway 1999–2004.
Results: Maternal smoking prevalence at inclusion during pregnancy were 5% (CI 95% 4–6) in the
intervention cohort compared to 7% (CI 95% 6–9), p = 0.03, in the control cohort. Of the pre-
pregnancy maternal smokers 25% (CI 95% 20–31) and 32% (CI 95% 26–38), p = 0.17, were still
smoking at inclusion in the intervention and control cohorts, respectively. Six weeks postnatal 72%
(CI 95% 59–83) and 68% (CI 95% 57–77), p = 0.34 of the maternal smokers at inclusion still
smoked. No significant difference in paternal smoking between the cohorts was found after the
intervention period. Data from the MBR showed a significantly higher proportion of women who
stopped smoking during pregnancy in Trondheim than in Bergen in 2003 and 2004, p = 0.03 and <
0.001, respectively.
Conclusion: No impact on parental smoking behaviour between the cohorts was observed after
the smoking intervention programme. Of the women who stopped smoking during pregnancy most
of them stopped smoking before the intervention. However, we observed a significantly higher
quitting rate in Trondheim than in Bergen in 2003 and 2004 which may have been facilitated by the
supplemental attention on smoking behaviour the PACT study initiated.
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Smoking in pregnancy is a well documented and poten-
tially avoidable risk factor for a multitude of conditions,
including miscarriage, low birth weight, perinatal death,
childhood asthma and atopic disease [1-3]. Despite evi-
dence-based knowledge of the harmful effects, tobacco
smoking is still prevalent during pregnancy.
Prevalence studies in the 1980s showed that one in three
pregnant women in Norway smoked during pregnancy, at
that time among the highest smoking prevalence in
Europe [4-6]. Eriksson et al. showed that the point preva-
lence of smoking at 18 weeks of gestation in Trondheim
was 34% in 1987 compared to 22% in 1994, a statistically
significant reduction. No effect of the national campaign
against smoking during pregnancy launched in 1989 was
found [7]. Public health interventions and smoking bans
have since then shown success in some Western countries
[8]. Norway has a history of more than 40 years of regula-
tion of tobacco advertising and tobacco smoking in pub-
lic. The 1975 Tobacco Act involved an advertising ban, 16
years age limit for buying tobacco products and labelling
of tobacco products. Restrictions on smoking in public
restaurants, bars, cafes, pubs and discotheques came in
1993, but a total ban on smoking in restaurants and bars
first took effect on June 1st 2004. The first national com-
prehensive mass media campaign on tobacco and health
for many years was accomplished during the study period
in 2003.
A review article from 2000 stated that pregnancy and the
postpartum period provide a window of opportunity to
promote smoking cessation[9]. A Cochrane review from
2004 concluded that smoking cessation programmes in
pregnancy reduce the proportion of women who continue
to smoke [10]. Further, a meta analysis from 2000 found
that a brief cessation counselling session of 5–15 minutes,
when delivered by a trained provider with the provision of
pregnancy specific self help materials, significantly
increased rates of cessation among pregnant smokers, and
these evidence based procedures were recommended to
be adopted by all prenatal health care providers [11].
In 1997 the Norwegian Government appointed Trond-
heim as a model city to try out a new public intervention
to counteract the rising incidence of asthma and allergic
diseases. It was a prerequisite that the intervention pro-
gramme should be possible to implement in ordinary pre-
and postnatal care, without extra cost, and within normal
consultation timeframe. The PACT-study was initiated in
collaboration between the Norwegian University of Sci-
ence and Technology (NTNU) and the municipality of
Trondheim. The PACT study is a still ongoing, controlled,
prospective, intervention study that was started in 2000
[12]. The primary objectives of the PACT study were to
investigate the effectiveness of the risk-factor intervention
on behavioural changes among parents, secondly to
investigate the efficacy on the incidence of allergic dis-
eases in the offspring from increasing omega-3- fatty acid
intake and reducing parental smoking and indoor damp-
ness [13].
The objectives of this study were to investigate parental
smoking behaviour during pregnancy after introduction
of a prenatal, structured, multi-disciplinary smoking ces-
sation programme in primary care, and to compare smok-
ing behaviour among pregnant women in the city of
Trondheim with Bergen and Norway.
Methods
The study was performed in the city of Trondheim, the
capitol city in middle Norway with 160 000 inhabitants
and approximately 2100 deliveries per year. The city holds
a University with 20 000 students and 4500 employees. In
all, 28 of 35 general practices (90 general practitioners),
all eight community based midwifes and all 20 maternity
health centres in Trondheim agreed to participate in the
PACT study.
Cohorts and subjects
Sequential birth cohorts were established to evaluate the
intervention programme. From September 1st 2000 to
May 30th 2002 all pregnant women who consulted their
GPs or community based midwifes for pregnancy care
were eligible to participate in the control cohort of the
PACT study. Of some 3600 eligible pregnant women in
Trondheim during this period, 1788 (50%) women were
included and completed the pregnancy questionnaire
(Q1), and 1023 (57%) of the participating women com-
pleted the questionnaire (Q2) six weeks after delivery
(Figure 1). Participating women in the control cohort
received common, nationwide recommended, advice on
life-style, including smoking behaviour, following the
routines each health-worker was familiar with at that
time.
From June 1st 2002 to December 15th 2004 women were
invited and included to the intervention cohort of the
study. Of some 5200 pregnant women eligible to partici-
pate in the intervention cohort during this period, 2051
(40%) women gave their consent and answered the preg-
nancy questionnaire, and 1109 (54%) of the participating
women completed the questionnaire six weeks after deliv-
ery.
All pregnant women were eligible to the PACT study if
they were able to understand and fill in a questionnaire in
Norwegian language with no other inclusion or exclusion
criteria for either cohort.Page 2 of 10
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The intervention programme on diet, indoor dampness,
and smoking cessation was developed in collaboration
with midwives, maternity care nurses, GPs, and parents as
a multiple health behaviour intervention. The smoking
intervention programme was a brief office intervention
Flow chartigure 1
Flow chart. The same questionnaires were used in both cohorts. Q1 = questionnaire during pregnancy, measurement of 
smoking behaviour at start pregnancy and at inclusion at first antenatal check-up. Q2 = questionnaire at six weeks postnatal, 
measurement of present smoking behaviour.
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Department of Health and Human Services Public Health
Service (USHPS) guideline "Treating Tobacco Use and
Dependence. Clinical Practice Guideline"[15]. From June
2002 the intervention was adopted by the city health
authorities to be implemented by all health professionals
as an integrated part of the recommended maternity care
life-style counselling programme in primary health care
throughout Trondheim, regardless of participation in the
PACT study or not. The intervention programme contin-
ued throughout pregnancy at GP and midwife consulta-
tions. The recommended primary care prenatal schedule
for follow-up in Norway was the same for both cohorts
and constitutes of 8–10 prenatal consultations with a GP
or midwife from week 8–10 in pregnancy. This pro-
gramme has been accessible to all women in Norway for
many years, free of charge, and with an attendance rate of
nearly 100%. The women were invited to bring their part-
ners to the consultations, and if he was a smoker they were
encouraged to make a smoking cessation effort together.
Midwifes, public health nurses and GPs were offered a
three hours course to improve smoking cessation counsel-
ling skills, to obtain a consistent intervention and inspire
enthusiasm [16]. All midwifes and 22 of the 28 participat-
ing group practices attended the course. In addition, all
participating midwifes and GPs were supplied with writ-
ten strategy guidelines describing the intervention in
detail. Some 7% of the participating women in the inter-
vention cohort were included by GPs that did not attend
the three hours course. All women included in the inter-
vention cohort were regarded as intervened upon whether
their GP had delivered the intervention or not. Self-help
materials to be offered to the participants were also dis-
tributed to all primary care health professionals. Continu-
ous smoking cessation groups were allocated to the
maternity care centres and administered by public health
nurses. The health professionals received four follow-up
newsletters during the intervention.
Outcome variables
PACT data
The primary outcome variable was self-reported parental
smoking behaviour at six weeks postnatal. The partici-
pants were asked to complete a self-reported life-style
questionnaire including smoking behaviour at the first
maternity clinic check-up (gestational week 8–12) and
later at six weeks after delivery. Parental smoking during
pregnancy was assessed with two questions at the antena-
tal questionnaire. The women were asked if they or their
partner were smoking at the beginning of pregnancy, if
they were smoking now and daily and/or weekly cigarette
consumption. A separate question was asked about the
total numbers of cigarettes smoked indoors. The same
questions were asked six weeks postnatal. Smoking was
coded as a dichotomous variable, if they were smoking
more than one cigarette a week they were coded as smok-
ers, if the answer was "no" they were coded as non-smok-
ers, and if the answers to all questions on smoking were
missing they were coded as missing. No biomarker such as
hair nicotine was measured.
National data
Aggregated data from the Medical Birth Registry of Nor-
way (MBR) were used to illustrate smoking cessation in
Norway and the two comparable cities of Bergen and
Trondheim from 1999 to 2004.
Bergen is the second largest city in Norway, with 245 000
inhabitants and around 3200 deliveries per year, with a
University with some 16 000 students. Smoking data from
the MBR were available from 1999–2004. These data are
collected as a mandatory procedure at discharge from any
maternity ward in Norway. Forms are completed by a
midwife or physician interview and by using the hospital
medical records. The women are asked if they smoked at
the beginning or end of pregnancy, and they can answer
"no", "occasionally" and "yes". Smoking was coded as a
dichotomous variable, "occasionally" and "yes" were
coded as smokers,"no" as non-smokers. Data were availa-
ble for approximately 90% of the women who gave birth
during the period from 1999 to 2004 according to infor-
mation from the MBR.
The non-responder study
To investigate if there was a selection bias among partici-
pants in the PACT study we conducted an non-responder
study where 391 parents who consecutively visited mater-
nal postnatal care were asked to complete a short and
anonymous questionnaire on age, socioeconomics, aller-
gic disease and smoking behaviour, regardless of partici-
pation in the PACT-study or not.
Educational data
Maternal and paternal education was not accounted for in
the original questionnaire. Thus, some 800 randomly
selected parents answered questions on education (797
women and 812 men), either written or by telephone
interview.
Approvals
The Regional Committee for Medical Research Ethics for
Central Norway approved the study (Ref 120–2000). The
study was granted license by the Norwegian Data Inspec-
torate to process personal health data and one of the par-
ents signed a written informed consent formula (Ref
2003/953-3 KBE/-).Page 4 of 10
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SPSS for Windows® ver.14.0 (Chicago, Ill. USA) was used
for all statistical analyses. Comparisons between groups
were tested by chi square tests for categorical data and
independent t-tests for continuous data. Confidence inter-
vals (95% CI) were estimated for prevalence and odds
ratio using binomial distribution for dichotomous data,
and normal distribution for continuous data. Confound-
ing factors were identified by a priori knowledge, and
maternal age at the beginning of pregnancy, parity; mari-
tal status, homeowner (as a proxy for social status) and
paternal smoking at the beginning of pregnancy were
tested in several models. The resulting set of covariates
included maternal age at the beginning of pregnancy, par-
ity and marital status. We used GLM with binomial regres-
sion in a predictive model (STATA ver. 10.0) to adjust
smoking prevalence at the beginning of pregnancy, at
inclusion and at 6 weeks post partum in both cohorts.
Parental smoking was stratified into smokers and non-
smokers at the beginning of pregnancy and at time of
inclusion, and binary logistic regression models were used
to estimate adjusted odds ratio (aOR) for smoking at
inclusion and at six weeks postnatal, respectively, in the
intervention cohort compared to the control cohort.
Finally, binary logistic regression models were used to
estimate aORs for the associations between smoking ces-
sation before inclusion (spontaneous quitting) and back-
ground factors The results are analysed and presented
according to the STROBE recommendations [17].
Results
Some 28 of 35 general practices in Trondheim included a
total of 2657 women into both cohorts by end 2004, rang-
ing from 14 to 348 per practice, with 69% of the practices
including more than 40 participants. The community
midwives included altogether 1181 women. This gave a
participation rate of about 44% of the eligible pregnant
women in Trondheim. The non-responder study on 391
parents showed no selection bias for participants in the
PACT-study regarding age, socioeconomics, allergic dis-
ease, or smoking behaviour (table 1).
Background characteristics of the intervention and control 
cohorts
There were significantly more primiparous women, fewer
single mothers, more educated women and more drop-
outs in the intervention cohort. The cohorts did not differ
regarding maternal age, paternal education; the number
of cigarettes smoked a day by mother or father, neither at
the beginning of pregnancy nor at inclusion. The charac-
teristics of the cohorts are presented in table 2.
Comparing dropouts from the intervention and control
cohorts neither their mean age, 28.7 years (SD 4.8) and
28.5 years (SD 4.8) p = 0.56, nor being a homeowner, OR
1.1 (CI 95% 0.9–1.3) p = 0.43, nor the proportion who
smoked more than 10 cigarettes a day, OR 1.1(CI 95%
0.7–1.6) did differ. There were, however, significantly
more single women among dropouts in the intervention
cohort, OR 1.3 (CI 95% 1.1–1.6) p = 0.004 (table 3).
Among the women who smoked at inclusion, 140 and
184 women in the intervention cohort and control
cohort, respectively, there was no significant difference in
dropouts as 80 smokers dropped out from the interven-
tion cohort and 90 smokers from the control cohort, (p =
0.15). Information on smoking among dropouts was
missing for 7% and 5% in the intervention and control
cohort, respectively.
Smoking prevalence
The maternal smoking prevalence in the intervention
cohort was significantly lower at the beginning of preg-
nancy and at inclusion, but not at six weeks post partum.
Paternal smoking prevalence did not differ between the
cohorts at the beginning of pregnancy, but was signifi-
cantly lower in the intervention cohort at inclusion and
six weeks post partum (table 4).
Table 1: The non-responder study (N = 391). Characteristics of responders and non-responders to the PACT study
Non-responders (n = 219) Responders (n = 172)
n % CI 95% n % CI 95% p-value
Atopy in the family* 120 55.0 48.4–61.6 109 63.4 56.2–70.6 0.1
Mothers smoking at the beginning of pregnancy 46 21.0 15.6–26.4 28 16.3 10.8–21.8 0.25
Mothers smoking now 23 10.6 6.5–14.7 16 9.3 5.0–13.6 0.74
Fathers smoking at the beginning of pregnancy 39 18.6 13.5–23.8 32 18.9 13.1–24.8 1
Fathers smoking now 37 17.5 12.5–22.5 23 13.5 8.4–18.6 0.32
Median Mean SD Median Mean SD p-value
Maternal age 30 30.8 5.1 30.5 30.7 4.8 0.89
Maternal education (years) 15 15.1 2.1 16 15.6 2.5 0.08
Fathers education (years) 15 15.1 3.1 16 15.3 2.9 0.64
*Atopy = mother or father or sibling reporting at least one atopic diseasePage 5 of 10
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Data stratified according to smoking behaviour at the
beginning of pregnancy demonstrated that in the inter-
vention cohort only one in four of the smoking women
continued to smoke from the beginning of pregnancy
until inclusion, with no significant difference between the
cohorts. In contrast, most men continued to smoke in the
same period, but significantly fewer in the intervention
cohort. Very few men and women started smoking from
the beginning of pregnancy until inclusion (table 5). In
one model participants with missing smoking data were
recoded as smokers. Neither in this model did we find any
significant difference between the cohorts regarding
smoking behaviour 6 weeks postnatal for women smok-
ing at inclusion, aOR = 0.72 (95% CI 0.42–1.22, p = 0.22)
When we stratified according to smoking behaviour at
inclusion we found that most women who smoked at
inclusion continued smoking during pregnancy, about 7
in 10 women smoked at six weeks postnatal, with no sig-
nificant difference between the cohorts. We found the
same result among their partners. Some two percent of
those who were non-smokers at inclusion were smoking
at six weeks postnatal with no significant difference
between the cohorts (table 6).
When we looked at both cohorts combined women who
were at risk for continued smoking after the beginning of
pregnancy and still smoking at inclusion were living sin-
gle, multiparous women and women who smoked more
than 10 cigarettes a day. At the beginning of pregnancy
518 (25%) of the women were smoking more than one
cigarette weekly, 25 women had missing data, and 493
women were included in the analysis (table 7). At high
risk for continued smoking at inclusion were multiparous
women smoking > = 10 cigarettes a day compared to all
other smoking women at the beginning of pregnancy, OR
3.5, p < 0.001.
Indoor smoking
At inclusion 18% of the parental smokers in the interven-
tion cohort, and 28% in the control cohort reported
indoor smoking (p = 0.01). At six weeks post partum only
one parent in the intervention cohort and nine parents
(5%) of the parental smokers reported indoor smoking (p
= 0.04). When all with missing data on indoor smoking
were recoded as indoor smokers 5% and 8% were indoor
smokers in the intervention cohort, and control cohort,
respectively.
Smoking cessation in Trondheim, Bergen and Norway
Data from MBR showed a quitting rate of about 30–40%
from 1999 to 2002 with no difference between Trond-
heim, Bergen and Norway. In 2003 and 2004 the propor-
tion of women who stopped smoking during pregnancy
in Trondheim increased seemingly more than in Bergen
Table 2: Characteristics of the intervention cohort (N = 2051) and the control cohort (N = 1788) at inclusion n = number of 
participants included in analysis
Intervention cohort Control cohort
n % 95% CI n % 95% CI p-value
Single mother* 1072 1.9 1.1–2.7 994 3.8 2.6–5.0 0.01
Primiparous 2051 56.6 54.5–58.7 1785 48.6 46.3–50.9 <0.001
n mean SD n mean SD
Maternal age (years) 2044 28.6 4.6 1766 28.8 4.7 0.14
Maternal education (years)† 283 16.1 2.2 514 15.8 2.3 0.05
Paternal education† 289 15.4 2.7 523 15.2 2.9 0.34
No. of cig. a day among smokers at the beginning of pregnancy Mother 462 8.6 7.9 475 8.0 6.1 0.19
Father 438 9.8 8.3 413 9.6 6.7 0.68
No. of cig. a day among smokers at inclusion Mother 140 5.3 7.4 184 4.9 4.0 0.57
Father 355 8.8 8.6 356 8.2 6.4 0.27
*Data from questionnaire 6 weeks postnatal
† Data available for 797 women and 812 men
Table 3: Maternal smoking prevalence among drop-outs
Intervention cohort Control cohort
n % 95% CI n % 95% CI p-value
Drop-outs* 942 45.9 42.7–49.8 765 42.8 39.3–46.3 0.05
Maternal smoking prevalence at the beginning of pregnancy 877 25.1 22.2–28.0 729 27.3 24.1–30.5 0.33
Maternal smoking prevalence during pregnancy 877 9.1 7.2–11.0 723 12.4 10.0–14.8 0.03
*Drop-outs = answered questionnaire in pregnancy but not answered questionnaire six weeks postnatalPage 6 of 10
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pregnancy smoking women stopped smoking at the
beginning of pregnancy or during pregnancy in 2004.
Discussion
We found a low smoking prevalence at inclusion, 4.9%
and 7.1% in the intervention cohort and the control
cohort, respectively. Only a quarter of the pre-pregnancy
smoking women still smoked at inclusion time with no
difference between the cohorts. During the intervention
period from inclusion until six weeks postnatal, 7 in 10
smokers still smoked six weeks postnatal with no signifi-
cant difference between the cohorts. At inclusion 18% and
28% reported indoor smoking in the intervention cohort
and the control cohort, respectively. At six weeks postnatal
very few of the smokers reported indoor smoking, only
one parent in the intervention cohort, and nine parents in
the control cohort.
Data from MBR illustrating quitting rates in Trondheim,
Bergen and Norway showed a seemingly higher propor-
tion of women who stopped smoking at the beginning or
during pregnancy in Trondheim than in Bergen in 2003
and 2004.
The study had a controlled design comparing sequential
total and unselected cohorts of pregnant women from the
beginning of pregnancy until six weeks postnatal. Choos-
ing a controlled design including whole birth cohorts
made it possible in a real life approach to test the interven-
tion programme. The assessment of smoking behaviour
was consistent through the observation period and across
cohorts, and independent of clinical practice. Further-
more, the majority of care providers were trained and
motivated to deliver the recommended intervention
modalities on repeated occasions both to those who
smoked and those who had quit smoking [18]. Finally,
when health professionals take part in a scheduled and
structured intervention, it may counteract any potential
negative beliefs and attitudes against promoting smoking
cessation [19]. The possibility to compare smoking cessa-
tion nationally and in the two comparable university cit-
ies of Trondheim and Bergen in the same period that the
sequential cohorts in PACT were investigated was an addi-
tional strength of the study.
The one year time difference between the control cohort
and intervention cohort might have biased the results
towards a better effect of the intervention due to secular
trends. However, this was the design of choice primarily
because a public and community based intervention
including the entire primary health care in the municipal-
ity would be impossible to implement without contami-
nating a co-existing control cohort. Secondly, comparing
total birth cohorts also ensured high conformity between
the cohorts regarding population size, race/ethnicity,
maternal educational level, income, environment, urban-
ization and social characteristics [20]. The use of self
reported questionnaires on smoking behaviour were
adopted based on documentation indicating equal or bet-
Table 4: Adjusted* parental smoking prevalence in the intervention cohort and the control cohort
Intervention cohort Control cohort
Maternal smoking prevalence % 95% CI % 95% CI aOR 95% CI p-value
At the beginning of pregnancy 21.7 19.4–24.1 25.1 22.7–27.6 0.78 0.61–1.00 0.05
At inclusion 4.9 3.5–6.4 7.1 5.6–8.6 0.63 0.42–0.95 0.03
6 weeks postnatal 5.8 4.3–7.4 7.6 6.0–9.2 0.72 0.49–1.06 0.09
Paternal smoking prevalence
At the beginning of pregnancy 21.9 19.2–24.6 24.7 21.8–27.5 0.86 0.69–1.07 0.17
At inclusion 17.0 14.5–19.5 21.2 18.5–23.9 0.76 0.60–0.97 0.03
6 weeks postnatal 14.5 12.2–16.9 17.9 15.4–20.4 0.78 0.60–1.00 0.05
*Parental smoking prevalence adjusted for maternal age at start pregnancy, first child and marital state.
Table 5: Prevalence of parental smokers at inclusion stratified according to smoking behavior at the beginning of pregnancy
Parental smoking prevalence at inclusion
Smoking behavior at the beginning of pregnancy Intervention cohort Control cohort
n % 95% CI n % 95% CI aOR 95% CI p-value
Mother non-smoking 1 0.1 0–0.8 1 0.1 0–0.9
Mother smoking 57 24.7 19.5–30.6 82 31.7 26.3–37.6 0.66* 0.43–1.04 0.17
Father non-smoking 3 0.4 0.1–1.2 3 0.5 0–1.4
Father smoking 162 75.3 69.2–80.7 176 84.6 79.1–88.9 0.58† 0.35–0.96 0.03
*Adjusted for first child, maternal age and paternal smoking at start pregnancy
†Adjusted for first child and maternal agePage 7 of 10
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questionnaire [21,22]. Furthermore, a Norwegian valida-
tion study had already shown that Norwegian pregnant
women generally reported their smoking habits correctly
[23]. We used no biomarkers for tobacco smoking, as this
is unfeasible in large epidemiologic studies, and earlier
studies have demonstrated that such biomarkers give little
or no additional accuracy to the registration of smoking
behaviour when compared to self reported smoking in
pregnancy [24,25].
Participation and dropouts
During the study period starting September 1st 2000 and
ending December 15th 2004, 3839 of some 8800 eligible
pregnant women in Trondheim took part in the PACT
study, giving a participation rate of 44%. The participa-
tion rate was a consequence of low inclusion activity
among many GPs and midwifes, and not a consequence
of self selection among women. There is no reason to
assume a selection bias, as confirmed by results from the
non-responder study which included 391 subjects.
Of the 3839 women that were included during pregnancy,
2132 (56%) answered the questionnaire six week postna-
tal. This is a high loss to follow-up, and most probably
due to forgetfulness or failing routines for follow-up
among the health professionals. One would also expect a
certain degree of exhaustion among GPs and midwives in
a study of such longevity [26]. If the loss to follow-up is
assigned to forgetfulness or low attention during follow-
up both among participants and health professionals, it
may be assumed that the participants are lost at random.
This is supported by the observation that baseline charac-
teristics between dropouts in the two cohorts only differed
for single mothers. If so, even a loss to follow-up of 60%
is shown not to represent important bias [27]. Impor-
tantly, we had almost no active withdrawals in either
cohort.
We found no significantly reduced parental smoking prev-
alence in the intervention cohort six weeks postnatal
when we performed a stratified analysis according to
smoking behaviour at inclusion. The high quitting rate
observed in both cohorts was apparently due to spontane-
ous quitting before inclusion. Therefore only a hardcore
of resilient smokers were left to intervene on, women who
had taken their choice of continued smoking during preg-
nancy probably despite knowledge of the harmful effects
and social stigma. In this respect multiparous women
who smoked more than 10 cigarettes a day were at highest
risk. This is in agreement with results from several other
smoking intervention studies in pregnancy [28,29].
We found a very low prevalence of reported indoor smok-
ing in both cohorts which may indicate that there was
awareness in both cohorts of the harmful effect of SHS on
Table 6: Comparison of parental smoking between the cohorts after the smoking intervention programme
Parental smoking prevalence 6 weeks post partum
Smoking behaviour Intervention cohort Control cohort
at inclusion: n % 95% CI n % 95% CI aOR 95% CI p-value
Mother non-smoking 20 2,1 1,3–3,2 27 3,2 2,2–4,6 0,77* 0,42–1,42 0,40
Mother smoking 42 72,4 59,1–83,3 57 67,9 57,3–76,9 1,54* 0,63–3,73 0,34
Father non-smoking 24 2,9 2,0–4,4 21 3,1 2,0–4,7 0,92† 0,53–1,59 0,76
Father smoking 116 69,9 62,5–76,4 134 74,0 67,2–79,9 0,61† 0,35–1,04 0,07
Stratified analysis according to smoking behaviour at inclusion, crude prevalence stated for smoking.
*aORs adjusted for maternal age, first child, and paternal smoking at the beginning of pregnancy
†aORs adjusted for first child and maternal age
Table 7: Logistic regression of background factors predicting maternal smoking at inclusion* among pre-pregnancy smokers
Adjusted odds ratio for smoking at inclusion
aOR 95% CI p-value
Maternal age < = 24 years vs. reference
> 31 years 1.57 0.82–3.02 0.18
Primiparous vs. reference
multiparous 1.71 1.09–2.69 0.02
Married or cohabitant vs. reference
living single 3.01 1.43–6.34 0.004
Mother smoking <= 10 cig. a day vs. reference
> 10 cig. a day 3.07 2.04–4.64 < 0.001
*(1 = smoking, n = 150) (0 = non-smoking = spontaneous quitters, n = 362)Page 8 of 10
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bility may also explain this result.
Smoking cessation in Trondheim and Bergen
The MBR aggregated data showed a higher quitting rate
during pregnancy in Trondheim than in Bergen after the
intervention programme in the PACT study commenced.
The MBR data for Trondheim comprise both women par-
ticipating in the PACT study and non-participating
women. The women in the two cities had been exposed
for the same national legislation and anti smoking cam-
paigns. What differ between the two cities are the PACT
study and the fact that the intervention programme was
adopted as an integrated part of the recommended mater-
nity care life-style counselling programme throughout
Trondheim. An interpretation may be that the PACT study
in this way have increased the attention on the health haz-
ards of smoking in pregnancy, both among GPs and mid-
wifes, but also among the parents to be, and in this way
brought about the significantly higher smoking cessation
rate observed in the MBR data for Trondheim compared
to Bergen.
Conclusion
A new smoking intervention programme as part of a mul-
tiple health behaviour intervention did not reduce paren-
tal smoking prevalence during pregnancy in the
intervention cohort compared to the control cohort. Most
women were spontaneous quitters and gave up smoking
early in pregnancy before the intervention took place. We
found a low indoor smoking prevalence in both cohorts,
which may reflect a high degree of awareness of the harm-
ful effects of smoking during pregnancy. Data from the
MBR showed a higher quitting rate in Trondheim com-
pared to Bergen in 2003 and 2004 which may have been
facilitated by the supplemental attention on smoking
behaviour the PACT study initiated.
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